{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:12:20Z","timestamp":1789823540278,"version":"4.0.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.revmed.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T20:46:20Z","timestamp":1487191580000},"page":"603-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Lupus \u00e9ryth\u00e9mateux syst\u00e9mique et lymphop\u00e9nie\u00a0: aspects cliniques et physiopathologiques"],"prefix":"10.1016","volume":"38","author":[{"given":"M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Argemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2017.01.005_bib0470","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.semarthrit.2015.05.009","article-title":"Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: prevalence and clinical impact\u2013a systematic literature review","volume":"45","author":"Carli","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0475","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0480","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0485","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1136\/lupus-2014-000078","article-title":"Haematological manifestations of lupus","volume":"2","author":"Fayyaz","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0490","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/0961203309103152","article-title":"Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study","volume":"18","author":"Dhir","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2017.01.005_bib0495","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.0007-0963.2004.05883.x","article-title":"The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship","volume":"150","author":"Wouters","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0500","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.1780180302","article-title":"Antilymphocyte antibodies in systemic lupus erythematosus","volume":"18","author":"Messner","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0505","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780160312","article-title":"Relative T-Cell Specificity of lymphocytotoxins from patients with systemic lupus erythematosus","volume":"16","author":"Lies","year":"1973","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0510","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.1780180609","article-title":"Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus","volume":"18","author":"Winfield","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0515","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0198-8859(96)00054-7","article-title":"Human CD4-reactive antibodies from SLE patients induce reversible inhibition of polyclonal T lymphocyte proliferation","volume":"49","author":"Lenert","year":"1996","journal-title":"Hum Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0520","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.172.7.4298","article-title":"Lupus IgG VH4,34\u00a0antibodies bind to a 220-kDa glycoform of CD45\/B220\u00a0on the surface of human B lymphocytes","volume":"172","author":"Cappione","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0525","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/eji.1830151012","article-title":"Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies","volume":"15","author":"Shoenfeld","year":"1985","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0530","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.51.6.713","article-title":"Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia","volume":"51","author":"Noguchi","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.01.005_bib0535","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1365-2249.1997.3691261.x","article-title":"Anti-ribosomal and \u201cP-peptide\u201d-specific autoantibodies bind to T lymphocytes","volume":"109","author":"Stafford","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0540","doi-asserted-by":"crossref","first-page":"672126","DOI":"10.1155\/2014\/672126","article-title":"Antilymphocyte antibodies in systemic lupus erythematosus: association with disease activity and lymphopenia","volume":"2014","author":"Li","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.revmed.2017.01.005_bib0545","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.4049\/jimmunol.152.7.3685","article-title":"Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus","volume":"152","author":"Emlen","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0550","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/art.1780400216","article-title":"In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases","volume":"40","author":"Lorenz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0555","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/10715762.2011.555765","article-title":"Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus","volume":"45","author":"Shah","year":"2011","journal-title":"Free Radic Res"},{"key":"10.1016\/j.revmed.2017.01.005_bib0560","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2249.1995.tb05540.x","article-title":"Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia","volume":"99","author":"Amasaki","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0565","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s102380200002","article-title":"Serum elevations of soluble Fas (CD95\/apo-I) concur in deregulating T cell apoptosis during active lupus disease","volume":"2","author":"Silvestris","year":"2002","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0570","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1191\/0961203303lu250oa","article-title":"Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95\/Apo-1) in active lupus","volume":"12","author":"Silvestris","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2017.01.005_bib0575","doi-asserted-by":"crossref","first-page":"38241","DOI":"10.1074\/jbc.274.53.38241","article-title":"Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95\u00a0death receptor","volume":"274","author":"Papoff","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2017.01.005_bib0580","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2249.1996.d01-849.x","article-title":"Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis","volume":"106","author":"Kaneko","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0585","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.92.3.811","article-title":"CTLA4\u00a0mediates antigen-specific apoptosis of human T cells","volume":"92","author":"Gribben","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.revmed.2017.01.005_bib0590","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00415-002-0781-6","article-title":"Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations","volume":"249","author":"Silva","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0595","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.2004.05848.x","article-title":"Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens","volume":"150","author":"Wenzel","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0600","first-page":"819634","article-title":"Multiple autoantibodies display association with lymphopenia proteinuria, and cellular casts in a large, ethnically diverse SLE patient cohort","volume":"2012","author":"Lu","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.revmed.2017.01.005_bib0605","first-page":"643","article-title":"Apoptosis and cell penetration by autoantibody may represent linked processes","volume":"17","author":"Williams","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0610","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/jaut.1996.0038","article-title":"The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and\/or cell damage","volume":"9","author":"Alarc\u00f3n-Segovia","year":"1996","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2017.01.005_bib0615","doi-asserted-by":"crossref","first-page":"725684","DOI":"10.1155\/2012\/725684","article-title":"Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients","volume":"2012","author":"Alegretti","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0620","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cellimm.2010.07.013","article-title":"Expression of CD55\u00a0and CD59\u00a0on peripheral blood cells from systemic lupus erythematosus (SLE) patients","volume":"265","author":"Alegretti","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0625","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0961203306071916","article-title":"Diminished expression of complement regulatory proteins (CD55\u00a0and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia","volume":"15","author":"Garcia-Valladares","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2017.01.005_bib0630","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2006.09.008","article-title":"The role of complement regulatory proteins (CD55\u00a0and CD59) in the pathogenesis of autoimmune hemocytopenias","volume":"6","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2017.01.005_bib0635","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.2001.03076.x","article-title":"Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus","volume":"115","author":"Papadaki","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0640","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/art.24257","article-title":"Increased expression of CD40\u00a0on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis","volume":"60","author":"Pyrovolaki","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0645","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1182\/blood-2014-04-568451","article-title":"Impact of interferon-\u03b3 on hematopoiesis","volume":"124","author":"De Bruin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.01.005_bib0650","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.187.1.79","article-title":"Impairment of T and B cell development by treatment with a type I interferon","volume":"187","author":"Lin","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0655","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4049\/jimmunol.1302112","article-title":"Activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus","volume":"192","author":"Palanichamy","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0660","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1182\/blood-2008-12-192559","article-title":"Interleukin-6\u00a0aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6. Sle1. Yaa animals","volume":"113","author":"Maeda","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.01.005_bib0665","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2003.tb06038.x","article-title":"Role of homeostatic chemokine and sphingosine-1-phosphate receptors in the organization of lymphoid tissue","volume":"987","author":"M\u00fcller","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2017.01.005_bib0670","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.27685","article-title":"Dysregulated expression of CXCR4\/CXCL12\u00a0in subsets of patients with systemic lupus erythematosus","volume":"62","author":"Wang","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0675","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cei.12791","article-title":"CXCR5\u00a0is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking","volume":"185","author":"Wiener","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0680","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.1780240402","article-title":"Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sj\u00f6gren's syndrome","volume":"24","author":"Fauci","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0685","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.20031104","article-title":"Inflammation controls B lymphopoiesis by regulating chemokine CXCL12\u00a0expression","volume":"199","author":"Ueda","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0690","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.smim.2007.10.004","article-title":"T cell immune reconstitution following lymphodepletion","volume":"19","author":"Williams","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0695","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1084\/jem.20071133","article-title":"IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells","volume":"205","author":"Tajima","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0700","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.20052187","article-title":"Autoimmune arthritis associated with mutated interleukin (IL)-6\u00a0receptor gp130\u00a0is driven by STAT3\/IL-7-dependent homeostatic proliferation of CD4+ T cells","volume":"203","author":"Sawa","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0705","doi-asserted-by":"crossref","first-page":"e3118","DOI":"10.1371\/journal.pone.0003118","article-title":"IL-21\u00a0limits peripheral lymphocyte numbers through T cell homeostatic mechanisms","volume":"3","author":"Datta","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.revmed.2017.01.005_bib0710","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew297","article-title":"T follicular helper cells, interleukin-21\u00a0and systemic lupus erythematosus","author":"Gensous","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.01.005_bib0715","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.4049\/jimmunol.181.4.2399","article-title":"Homeostatic proliferation in the mice with germline FoxP3\u00a0mutation and its contribution to fatal autoimmunity","volume":"181","author":"Chang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0720","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood-2008-12-192120","article-title":"Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development","volume":"114","author":"Le Campion","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.01.005_bib0725","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.4049\/jimmunol.168.12.5979","article-title":"Cutting edge: depletion of CD4+ CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease","volume":"168","author":"McHugh","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0730","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2010.04309.x","article-title":"Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia","volume":"164","author":"G\u00f3mez-Mart\u00edn","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0735","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ni.2319","article-title":"TGF-\u03b2 signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation","volume":"13","author":"Zhang","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0740","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1084\/jem.181.6.2129","article-title":"Cells are the target of negative selection in the B cell compartment","volume":"181","author":"Carsetti","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0745","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.revmed.2017.01.005_bib0750","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/art.22224","article-title":"Systemic lupus erythematosus in a multiethnic US cohort XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual","volume":"55","author":"Vil\u00e1","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0755","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.semarthrit.2015.11.003","article-title":"Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort","volume":"45","author":"Gonz\u00e1lez-Naranjo","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0760","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/rheumatology\/39.12.1316","article-title":"Prognostic parameters for flare in systemic lupus erythematosus","volume":"39","author":"Mirzayan","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2017.01.005_bib0765","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1002\/art.25019","article-title":"Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus","volume":"60","author":"Huang","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0770","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.thromres.2014.09.005","article-title":"Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum\u00a0?: a case control study","volume":"134","author":"Merayo-Chalico","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.revmed.2017.01.005_bib0775","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2017.01.005_bib0780","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/art.39070","article-title":"Serious infections among adult medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis","volume":"67","author":"Feldman","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0785","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1000\u00a0patients european working party on systemic lupus erythematosus","volume":"78","author":"Cervera","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2017.01.005_bib0790","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/qjmed\/hci155","article-title":"Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus","volume":"99","author":"Ng","year":"2006","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2017.01.005_bib0795","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/hct046","article-title":"Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study","volume":"106","author":"Merayo-Chalico","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2017.01.005_bib0800","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MD.0b013e31818ec711","article-title":"Acute viral infections in patients with systemic lupus erythematosus: description of 23\u00a0cases and review of the literature","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2017.01.005_bib0805","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/BOR.0000000000000084","article-title":"Update on infections and vaccinations in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"26","author":"Pasoto","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0810","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.revmed.2009.03.019","article-title":"[Cytomegalovirus and systemic lupus: severe infection and difficult diagnosis]","volume":"30","author":"Declerck","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.01.005_bib0815","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/s10165-012-0651-8","article-title":"Risk factors associated with elevated blood cytomegalovirus pp65\u00a0antigen levels in patients with autoimmune diseases","volume":"23","author":"Fujimoto","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0820","doi-asserted-by":"crossref","first-page":"370516","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"2012","author":"Draborg","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0825","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","article-title":"Defective control of latent epstein-barr virus infection in systemic lupus erythematosus","volume":"172","author":"Kang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0830","doi-asserted-by":"crossref","first-page":"e1002328","DOI":"10.1371\/journal.ppat.1002328","article-title":"Exhausted cytotoxic control of epstein-barr virus in human lupus","volume":"7","author":"Larsen","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.revmed.2017.01.005_bib0835","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.leukres.2014.06.025","article-title":"Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies","volume":"38","author":"Apor","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.revmed.2017.01.005_bib0840","doi-asserted-by":"crossref","first-page":"e000051","DOI":"10.1136\/lupus-2014-000051","article-title":"Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy","volume":"1","author":"Knight","year":"2014","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.revmed.2017.01.005_bib0845","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0961203312470186","article-title":"Increased incidence of herpes zoster among patients with systemic lupus erythematosus","volume":"22","author":"Chakravarty","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2017.01.005_bib0850","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2340\/00015555-1454","article-title":"Lymphopaenia, anti-Ro\/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus","volume":"93","author":"Hu","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0855","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1002\/art.38804","article-title":"Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases","volume":"66","author":"Rondaan","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0860","doi-asserted-by":"crossref","first-page":"e0144918","DOI":"10.1371\/journal.pone.0144918","article-title":"National lupus hospitalization trends reveal rising rates of herpes zoster and declines in pneumocystis pneumonia","volume":"11","author":"Murray","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.revmed.2017.01.005_bib0865","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00296-008-0721-6","article-title":"Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus","volume":"29","author":"Lertnawapan","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2017.01.005_bib0870","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0875","first-page":"1186","article-title":"Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus","volume":"23","author":"Kadoya","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0880","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rhu.0000221794.24431.36","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue disease","volume":"12","author":"Li","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0885","first-page":"1191","article-title":"Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia","volume":"19","author":"Porges","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0890","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.semarthrit.2014.06.001","article-title":"Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis","volume":"44","author":"Wang","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0895","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0961203313496342","article-title":"Invasive fungal infections in Argentine patients with systemic lupus erythematosus","volume":"22","author":"Vinicki","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2017.01.005_bib0900","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","article-title":"Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases","volume":"60","author":"Molloy","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.01.005_bib0905","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2008.07.006","article-title":"Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?","volume":"8","author":"Molloy","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2017.01.005_bib0910","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12016-012-8327-x","article-title":"Systemic lupus erythematosus, progressive multifocal leukoencephalopathy, and T-CD4+ lymphopenia","volume":"43","author":"Brand\u00e3o","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0915","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e3282887e91","article-title":"Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults","volume":"21","author":"Lesprit","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2017.01.005_bib0920","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/14397595.2015.1112467","article-title":"Safety and efficacy of upfront graded administration of trimethoprim-sulfamethoxazole in systemic lupus erythematosus: a retrospective cohort study","volume":"26","author":"Suyama","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0925","first-page":"480","article-title":"Frequency of adverse drug reactions in patients with systemic lupus erythematosus","volume":"30","author":"Pope","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.01.005_bib0465","series-title":"ZOSTAVAX, vaccin zona vivant att\u00e9nu\u00e9","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2017"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317300279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317300279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:38:05Z","timestamp":1759336685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866317300279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":93,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0248866317300279"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2017.01.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus \u00e9ryth\u00e9mateux syst\u00e9mique et lymphop\u00e9nie\u00a0: aspects cliniques et physiopathologiques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}